Literature DB >> 2659889

Extracellular matrix biosynthesis by cultured fetal rat lung epithelial cells. I. Characterization of the clone and the major genetic types of collagen produced.

B P Leheup1, S J Federspiel, M L Guerry-Force, N T Wetherall, P A Commers, S J DiMari, M A Haralson.   

Abstract

A new cell line of fetal rat lung origin has been established using the outgrowth procedure. One clone (2G3) isolated by this procedure exhibited during early passages some of the transmission electron microscopic features (e.g., lamellar bodies) indicative of type II pneumocytes and was selected for further study. This cell line has a stable modal chromosome number of 44 and has not been found to develop tumors in athymic rodents. The clone exhibits a biphasic growth curve with an initial generation time of approximately 22 hours at 37 degrees C. The cultures are not contact inhibited but rather develop an organized secondary growth pattern. Initially after subculture, a monolayer is formed consisting of cells which exhibit a cobblestone appearance. After development of this monolayer, a secondary growth pattern emerges. This latter phase of growth is characterized by spindle-shaped cells displaying a pattern of organization that delimits lumina on top of the initial monolayer. At the ultrastructural level, desmosomes are observed, and concurrent with the development of the secondary growth pattern, there is the appearance of dense cytoplasmic structures which resemble lamellar bodies. Based upon the origin, growth properties, and morphologic features of the cells, this clone has been designated fetal rat lung epithelial (FRLE) cells. The collagens secreted into the culture medium and present in the cell layers of FRLE cell cultures, which have developed the secondary growth pattern, were isolated using limited pepsin digestion and differential salt fractionation. Polyacrylamide gel electrophoresis under denaturing conditions indicated that FRLE cells synthesized components corresponding to the chains present in types I, III, IV, and V collagen molecules with no major differences occurring between the profiles of cell-associated and secreted molecules. Carboxymethyl-trisacryl chromatographic analysis revealed that approximately 80% of the collagen synthesized was type I and that approximately 20% of this genetic type of collagen was recovered as the type I homotrimer. Types III, IV, and V molecules accounted for 16, 2, and 3%, respectively, of the total collagen synthesized. Additionally, the type V collagen synthesized by FRLE cells was found to have the molecular compositions alpha 1(V) alpha 2(V) alpha 3(V) and [alpha 1(V)]3. These observations suggest that the collagen biosynthetic profile of the fetal or immature type II cell may differ from that of the fully differentiated type II pneumocyte. Furthermore, it is proposed that cultured FRLE cells may be a useful in vitro model system for investigating the regulation of macromolecular synthesis in and the differentiation and maturation of the fetal alveolar epithelial cell.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659889

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells.

Authors:  J J Creely; S J DiMari; A M Howe; M A Haralson
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

2.  Frequent aberrant methylation of p16INK4a in primary rat lung tumors.

Authors:  D S Swafford; S K Middleton; W A Palmisano; K J Nikula; J Tesfaigzi; S B Baylin; J G Herman; S A Belinsky
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 3.  Alveolar type II cells at the crossroad of inflammation, fibrogenesis, and neoplasia.

Authors:  U Saffiotti
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Type I collagen formation in rat type II alveolar cells immortalised by viral gene products.

Authors:  R Matsui; R H Goldstein; K Mihal; J S Brody; M P Steele; A Fine
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

5.  Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion.

Authors:  Elena Makareeva; Sejin Han; Juan Carlos Vera; Dan L Sackett; Kenn Holmbeck; Charlotte L Phillips; Robert Visse; Hideaki Nagase; Sergey Leikin
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

6.  Production of recombinant human type I procollagen homotrimer in the mammary gland of transgenic mice.

Authors:  P D Toman; F Pieper; N Sakai; C Karatzas; E Platenburg; I de Wit; C Samuel; A Dekker; G A Daniels; R A Berg; G J Platenburg
Journal:  Transgenic Res       Date:  1999       Impact factor: 2.788

7.  Effects of epidermal growth factor on collagen synthesis by an epithelioid cell line derived from normal rat kidney.

Authors:  J J Creely; S J DiMari; A M Howe; C P Hyde; M A Haralson
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

8.  Chronic nicotine exposure stimulates biliary growth and fibrosis in normal rats.

Authors:  Kendal Jensen; Syeda Afroze; Yoshiyuki Ueno; Kinan Rahal; Amber Frenzel; Melanie Sterling; Micheleine Guerrier; Damir Nizamutdinov; David E Dostal; Fanyin Meng; Shannon S Glaser
Journal:  Dig Liver Dis       Date:  2013-04-13       Impact factor: 4.088

9.  Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases.

Authors:  Sejin Han; Elena Makareeva; Natalia V Kuznetsova; Angela M DeRidder; Mary Beth Sutter; Wolfgang Losert; Charlotte L Phillips; Robert Visse; Hideaki Nagase; Sergey Leikin
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

10.  Establishment of immortalized alveolar type II epithelial cell lines from adult rats.

Authors:  K E Driscoll; J M Carter; P T Iype; H L Kumari; L L Crosby; M J Aardema; R J Isfort; D Cody; M H Chestnut; J L Burns
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995 Jul-Aug       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.